SEC Form 5 · accession 0001209191-18-009704
Biohaven Pharmaceutical Holding Co Ltd. · BHVN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Berman
Officer — Chief Medical Officer
Period of report
Dec 31, 2017
Accepted (ET)
Feb 13, 2018 · 5:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001689813
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF1 | Nov 29, 2017 | G | 6,000 | $0.00 | D | 488,000 | I | By Berman Marital Trust |
| Common Shares | holding | — | — | — | 611,000 | I | By Berman Family Trust | |
| Common Shares | holding | — | — | — | 50 | I | Owned by spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the number of shares owned by the Berman Marital Trust as of December 31, 2017 and does not take into consideration subsequent sales.